COA, BMR & BPR: Documents Every Pharma Buyer Should Ask For

COA, BMR & BPR: Documents Every Pharma Buyer Should Ask For

Every pharma batch produces paperwork. A lot of it. And most brand owners, receiving a batch from their contract manufacturer, file the documents without reading them â—€ assuming that if the manufacturer sent them, they must be correct.

The documents are the quality record. They tell you whether the batch that just left the factory is the batch you contracted for, at the specification you agreed to, tested to the methods the pharmacopoeia requires. A COA that isn’t read is a quality assurance system that isn’t functioning.

This guide is about reading the documents, not just holding them â—€ and about knowing which ones to ask for, what a good document looks like, and what the specific entries mean.

Related quality reading: Quality Control in Pharma Contract Manufacturing · How to Choose a Third-Party Pharma Manufacturer · Revised Schedule M GMP Compliance Guide

Document 1: The COA â—€ Your Primary Quality Evidence

A real Batch Manufacturing Record (BMR) on the production floor — Saar Biotech Baddi

The Certificate of Analysis is the summary document of a batch’s QC testing. It is what you should receive â—€ and read â—€ before accepting every batch.

What a complete COA looks like:

CERTIFICATE OF ANALYSIS

Product Name:     Azithromycin Dry Syrup 200mg/5ml
Batch No.:        SB-2026-AZI-043
Mfg. Date:        October 2026
Exp. Date:        October 2028
Batch Size:       2,000 units (30ml bottles)
Manufacturing Site: [Licensed facility name and address]

TEST RESULTS

Parameter           Specification        Result          Status
â‗€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€—€€
Description         White to off-white   Off-white       PASS
                    powder, free from    powder, free
                    visible particles    from particles
pH (reconstituted)  3.5 â—€œ 5.5           4.1             PASS
Assay (HPLC)        95.0% â—€œ 105.0%      98.7%           PASS
Water content       NMT 3.0% w/w        1.8%            PASS
Fill volume         30ml ± 2ml          30.2ml          PASS
Microbial limits    TAMC: NMT 100 cfu/ml   <10 cfu/ml  PASS
                    TYMC: NMT 10 cfu/ml    <10 cfu/ml  PASS

Analytical Reference: Test Report No. TR-SB-2026-AZI-043

Authorized by: [QA Manager name, signature, date]

What’s wrong with a COA that just says “PASS”:

A COA that lists parameters with only “PASS” or “COMPLIES” â—€ without the actual test results â—€ is not a valid GMP document. It tells you nothing about whether the assay is 99.8% or 95.1% â—€ both pass the 95â—€œ105% specification, but one gives you essentially no headroom if stability degrades. Insist on actual test result values.

The 'Complies' COA Is a Red Flag
A COA that records test results as “Complies” rather than actual numerical values is non-compliant with Revised Schedule M data integrity requirements. Under ALCOA+ principles, test data must be recorded as the actual observation â—€ not a transcribed interpretation. If the COA you receive shows “Complies” against parameters that should have numerical results (assay, pH, fill volume, viscosity), ask for the analytical test report that contains the actual values. If this is refused, treat it as a significant quality concern.

Document 2: The BMR â—€ The Manufacturing Truth Record

The Batch Manufacturing Record (BMR) is the document that records everything that happened during manufacturing. You won’t typically hold this document as a brand owner â—€ it stays at the manufacturer. But understanding what it contains tells you what a GMP-compliant manufacturer is doing versus one that isn’t.

A complete BMR for a liquid formulation contains:

  • Raw material dispensing records â—€ each ingredient weighed and reconciled against the formula, with analyst signature and double-check counter-signature
  • Equipment cleaning verification â—€ equipment cleaning status confirmed before batch start (prevents cross-contamination from previous product)
  • In-process parameters â—€ temperature at mixing stages, mixing time and speed, pH at each critical step, in-process viscosity
  • Hold times â—€ if the bulk was held before fill, the duration, temperature, and storage conditions are recorded
  • Fill operations â—€ fill volume spot checks (number of units checked, results, acceptability)
  • Deviations â—€ any process deviation from the master formula, with investigation and disposition documented

WHO GMP guidance states: “Batch records shall be retained for at least one year after the expiry date of the batch.” Under Revised Schedule M, this is enforceable domestically. [Source: WHO Technical Report Series 986]

Document 3: The BPR â—€ Where Label Errors Live

The Batch Packaging Record is the document most often overlooked by brand owners â—€ and the one most likely to catch (or miss) the errors that directly affect a patient.

Label reconciliation is the critical section:

LABEL RECONCILIATION (from BPR)

Labels issued at start of packing:    2,050 units
Labels affixed to product:            2,000 units
Labels rejected (printing defects):       45 units
Labels destroyed (reconciliation):         5 units
                                          â‗€—€—€—€—€—€—€—€€
Total accounted for:                  2,050 units ✓

Discrepancy: 0 â—€ Reconciliation PASSED

Verified by: [Packaging supervisor name, signature, date]

Any discrepancy in this reconciliation must be investigated before the BPR is approved and the batch released. Unaccounted labels are a GMP deviation â—€ always.

The Dispatch Documentation Checklist

Before accepting a batch dispatch from your manufacturer, you should hold:

DocumentWho Provides ItWhen You Receive It
COA with test report referenceManufacturer QABefore or with dispatch
Invoice and delivery challanManufacturer accountsWith dispatch
Transport declaration (if controlled substance)Manufacturer regulatoryWith dispatch
Cold chain temperature record (if applicable)Transporter / manufacturerOn delivery
Regulatory form 26 (where applicable for interstate movement)Manufacturer regulatoryWith dispatch

For drug license filing purposes, ask your manufacturer for:

  • A sample BMR extract (anonymised) demonstrating their documentation standard
  • Stability data for the product (at minimum 3 months accelerated at 40°C/75% RH)
  • Analytical test report template for the product category

Conclusion

The documents are the quality system. A COA with actual test values tells you the batch is what you contracted for. A BMR that a manufacturer can produce on request tells you their process is under control. A BPR with clean label reconciliation tells you the right product is in the right box.

Ask for them. Read them. File the ones that pass and investigate the ones that don’t.

Frequently Asked Questions

What should a COA for a pharmaceutical liquid product contain?
A complete, GMP-compliant COA for a pharmaceutical liquid product should contain: the product name and batch number (matching the physical label), the manufacturing date and expiry date, the name and address of the manufacturing facility, the specification against which each test was performed (including the reference â—€ IP/BP/in-house), the test method used for each parameter, the actual test results (not just ‘complies’), the specification limit for each parameter, and the pass/fail result for each test. For a syrup or suspension, mandatory tests typically include: description (appearance), pH, assay (active content by HPLC, expressed as % of label claim), viscosity, fill volume, microbial limits (TAMC/TYMC), and preservative effectiveness (if applicable). The COA should be signed and dated by a qualified QA person or designated authority.
What is the difference between a BMR and a BPR?
A BMR (Batch Manufacturing Record) is the document that follows the product from raw material dispensing through to the end of manufacturing â—€ it records every step of the production process: ingredient weights, equipment used, process parameters (temperature, mixing time, pH at each stage), in-process check results, and operator signatures at each step. A BPR (Batch Packaging Record) covers the packaging phase â—€ it records label reconciliation (how many labels were issued vs how many were used vs how many were destroyed), batch number and expiry date verification, line clearance (ensuring no material from the previous batch is present), fill volume spot checks, and packaging yield. Both documents together constitute the complete batch record for a product and are kept by the manufacturer under GMP for the product’s shelf life plus additional years. As a brand owner, you generally receive the COA (summary document); the BMR and BPR remain at the manufacturer.
When should a brand owner ask to see a BMR?
As a standard practice, brand owners don’t receive BMRs for routine batch releases â—€ that’s the manufacturer’s internal quality record. However, there are specific situations where you should ask to see (or review) the BMR: when a batch has been placed on hold or returned for quality reasons; when an HPLC assay result is near the specification limit and you want to understand the manufacturing conditions that produced it; during a facility qualification audit before your first batch; and if a product complaint or adverse event requires root-cause investigation at the manufacturing level. In all these cases, a manufacturer who refuses access to the relevant BMR section â—€ or who claims the BMR is ’too sensitive to share’ â—€ should be treated as a significant quality concern.
What does 'label reconciliation' in a BPR mean and why does it matter?
Label reconciliation is the process of accounting for every label issued to the packaging line at the start of a batch. At the end of packing, the total labels used = labels affixed to product + labels rejected/destroyed. If the number doesn’t add up, some labels are unaccounted for â—€ which could mean they were affixed to a different product (mislabelling), taken off-site (serious GMP breach), or simply miscounted (process error). Label reconciliation is one of the most important patient safety controls in pharmaceutical packaging because a mislabelled product is the direct root cause of one of the most dangerous medication errors. A BPR that shows a label reconciliation discrepancy should never be signed off without investigation and resolution.
What is an out-of-specification (OOS) result and what happens if one occurs on my batch?
An out-of-specification (OOS) result occurs when a QC test result falls outside the specification limit for that parameter. For example, if the HPLC assay specification for your syrup is 95â—€œ105% of label claim, an assay result of 92% is OOS. Under GMP, an OOS result triggers a mandatory investigation protocol: the analyst’s work is verified for errors; a second analyst repeats the test independently; if the OOS is confirmed, the manufacturing conditions are investigated for root cause. If the OOS is confirmed and a genuine assignable cause is found, the batch may be rejected or â—€ depending on the nature of the deviation â—€ reprocessed if the product specification and procedure permits it. Reprocessing is a documented, controlled procedure, not just ’re-blending and retesting.’ You should be notified of any OOS result on your batch and informed of the investigation outcome before dispatch.
About Saar Biotech
WHO-GMP Certified
2250+ B2B Partners
240+ Products
Baddi Facility
Learn about our facility
Manufacturing Assurance

Why Choose Saar Biotech as Your Contract Manufacturing Partner?

Across every dosage form and every therapeutic area, Saar Biotech maintains the same uncompromising standards — because your brand's reputation depends on it.

WHO-GMP Certified

All dosage forms manufactured under WHO-GMP and ISO 9001:2015 in Baddi, India.

30–45 Day Turnaround

From artwork approval to first dispatch — delivered on time, India-wide.

Complete Regulatory Support

DCGI licensing, state permissions, COA issuance — handled by our team.

Segregated Lines

Dedicated Beta-Lactam and Non-Beta-Lactam manufacturing blocks for absolute purity.

240+ Approved Formulations
2250+ B2B Partners Served
Schedule M Compliant Manufacturing
30–45 Day Turnaround (Days)
Call Us
WhatsApp
Email